Todays Report: The Tradewinds Capital Management LLC decides to keep it stake in Thermo Fisher Scientific Inc. (TMO) to the level of $143,000

The Tradewinds Capital Management LLC decides to keep it stake in Thermo Fisher Scientific Inc. (TMO) to the level of $143,000

Tradewinds Capital Management LLC maintained its position in Thermo Fisher Scientific Inc. (NYSE:TMO) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 967 shares of the company’s stock at the end of the second quarter. Tradewinds Capital Management LLC’s holdings in Thermo Fisher Scientific were worth $143,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Signaturefd LLC boosted its position in Thermo Fisher Scientific by 10.6% in the second quarter. Signaturefd LLC now owns 842 shares of the company’s stock worth $124,000 after buying an additional 81 shares in the last quarter. Catawba Capital Management VA boosted its position in Thermo Fisher Scientific by 9.3% in the second quarter. Catawba Capital Management VA now owns 1,642 shares of the company’s stock worth $243,000 after buying an additional 140 shares in the last quarter. Parametrica Management Ltd acquired a new position in Thermo Fisher Scientific during the second quarter worth approximately $271,000. Alpha Windward LLC boosted its position in Thermo Fisher Scientific by 21.3% in the second quarter. Alpha Windward LLC now owns 1,836 shares of the company’s stock worth $271,000 after buying an additional 322 shares in the last quarter. Finally, Park Avenue Securities LLC acquired a new position in Thermo Fisher Scientific during the second quarter worth approximately $284,000. 87.38% of the stock is currently owned by institutional investors.

Thermo Fisher Scientific Inc. (NYSE:TMO) traded down 0.66% during trading on Monday, hitting $150.71. The stock had a trading volume of 1,155,934 shares. The firm has a 50 day moving average of $153.51 and a 200-day moving average of $151.02. Thermo Fisher Scientific Inc. has a one year low of $119.75 and a one year high of $160.68. The company has a market cap of $59.42 billion, a P/E ratio of 30.15 and a beta of 0.97.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Thursday, July 28th. The company reported $2.03 earnings per share for the quarter, beating the consensus estimate of $2.01 by $0.02. The business had revenue of $4.54 billion for the quarter, compared to the consensus estimate of $4.50 billion. Thermo Fisher Scientific had a return on equity of 14.70% and a net margin of 11.35%. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter last year, the business posted $1.84 earnings per share. Equities analysts anticipate that Thermo Fisher Scientific Inc. will post $8.17 earnings per share for the current fiscal year.

A number of research firms recently commented on TMO. Zacks Investment Research raised Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $178.00 price target on the stock in a report on Monday, August 1st. Citigroup Inc. boosted their price target on Thermo Fisher Scientific from $160.00 to $182.00 and gave the stock a “buy” rating in a report on Friday, July 29th. JPMorgan Chase & Co. began coverage on Thermo Fisher Scientific in a report on Thursday, September 22nd. They set an “overweight” rating and a $180.00 price objective on the stock. Goldman Sachs Group Inc. reaffirmed a “buy” rating on shares of Thermo Fisher Scientific in a report on Wednesday, July 6th. Finally, Jefferies Group reaffirmed a “hold” rating on shares of Thermo Fisher Scientific in a report on Thursday, August 4th. Two research analysts have rated the stock with a hold rating and seventeen have issued a buy rating to the company’s stock. The company currently has an average rating of “Buy” and an average target price of $162.37.

In related news, Director C Martin Harris sold 390 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, August 5th. The stock was sold at an average price of $157.33, for a total transaction of $61,358.70. Following the transaction, the director now owns 4,648 shares in the company, valued at $731,269.84. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Thomas W. Loewald sold 913 shares of Thermo Fisher Scientific stock in a transaction that occurred on Friday, August 26th. The stock was sold at an average price of $151.92, for a total value of $138,702.96. Following the transaction, the insider now owns 39,983 shares in the company, valued at approximately $6,074,217.36. The disclosure for this sale can be found here. 0.52% of the stock is owned by insiders.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Related posts

Leave a Comment